CIK 0001850270
- Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- EIN
- 981586514
- Phone
- +1 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 4 Planned sale SVP of Regulatory Development sold 17,238 shares at $2.50 ($43,095)
- 4 Planned sale SVP of Regulatory Development sold 84,403 shares at an average $1.73 ($146,005)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Legal Officer acquired 81,928 shares (conversion)
- 4 Conversion SVP of Regulatory Development acquired 137,073 shares (conversion)
- 4 Conversion Director acquired 748,952 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Former 10% Owner sold 7,256,367 shares at $1.31 ($9,498,584)
- 4 Open-market sale 10% owner sold 752,800 shares at an average $1.31 ($987,946)
- 4 Open-market sale 10% owner sold 576,700 shares at an average $1.56 ($897,872)
- 4 Open-market sale 10% owner sold 209,833 shares at an average $1.60 ($334,948)
- 4 Open-market sale 10% owner sold 405,400 shares at an average $1.70 ($688,100)
- 4 Conversion Director acquired 5,289,055 shares (conversion)
- 4 Open-market sale 10% owner sold 391,400 shares at an average $1.65 ($645,514)
- 4 Open-market sale 10% owner sold 321,473 shares at an average $1.77 ($567,573)
- 4 Open-market sale 10% owner sold 447,500 shares at an average $2.01 ($899,963)
Page 4 of 8 · 153 filings